Company at a Glance
Price
Infographic
Overview
Merck is a global pharmaceutical and chemical company founded in 1668 in Darmstadt, Germany. It was originally a supplier of traditional chemicals, but later expanded into pharmaceuticals, life sciences, and performance materials. Merck is also known as Merck KGaA, as it is a family-owned company with around 50% of its shares controlled by the descendants of its founder, Friedrich Jacob Merck.
The company has a strong presence in Europe and the United States, as well as in emerging markets such as China, India, and Latin America. It employs over 57,000 people and generates annual revenues of around 14 billion euros.
Merck's pharmaceutical division focuses on developing and commercializing innovative medicines in various therapeutic areas, including oncology, neurology, immunology, and cardiovascular diseases. Its life sciences division provides products and services for research, development, and production in the biopharmaceutical and biotechnological industries. The performance materials division provides materials and technologies for various industries, including healthcare, electronics, coatings, and cosmetics.
The company's mission is to "empower scientists and engineers to create and make life-changing innovations that improve people's lives." It is committed to sustainability and has set ambitious targets to reduce its environmental impact, promote diversity and inclusion, and improve access to healthcare for underserved populations.
Merck is also actively involved in corporate social responsibility initiatives, including providing disaster relief and supporting education and community development programs around the world.
What is special about the company?
π Want to read more about Merck?
Sign up for free
or
log in
π₯ Free eBook for new users: "The Checklist Value Investor β A Smarter Way to Pick Stocks"
TWVyY2sgaX MgYSBnbG9i YWwgcGhhcm 1hY2V1dGlj YWwgYW5kIG hlYWx0aGNh cmUgY29tcG FueSB0aGF0 IGhhcyBiZW VuIGluIG9w ZXJhdGlvbi Bmb3Igb3Zl ciAzNTAgeW VhcnMsIG1h a2luZyBpdC BvbmUgb2Yg dGhlIG9sZG VzdCBhbmQg bGFyZ2VzdC BwaGFybWFj ZXV0aWNhbC Bjb21wYW5p ZXMgaW4gdG hlIHdvcmxk LiBJdCBoYX MgYSBsb25n IGhpc3Rvcn kgb2YgaW5u b3ZhdGlvbi BhbmQgcmVz ZWFyY2gsIG xlYWRpbmcg dG8gdGhlIG RldmVsb3Bt ZW50IG9mIG 51bWVyb3Vz IG1lZGljYX Rpb25zIGFu ZCB2YWNjaW 5lcyB0aGF0 IGhhdmUgc2 lnbmlmaWNh bnRseSBpbX Byb3ZlZCBn bG9iYWwgaG VhbHRoLiBU aGUgY29tcG FueSBhbHNv IGhhcyBhIH N0cm9uZyBj b21taXRtZW 50IHRvIHN1 c3RhaW5hYm lsaXR5IGFu ZCBjb3Jwb3 JhdGUgcmVz cG9uc2liaW xpdHksIGVt cGhhc2l6aW 5nIGV0aGlj YWwgYnVzaW 5lc3MgcHJh Y3RpY2VzIG FuZCBnaXZp bmcgYmFjay B0byB0aGUg Y29tbXVuaX RpZXMgaW4g d2hpY2ggaX Qgb3BlcmF0 ZXMuIE1lcm NrIGlzIGFs c28ga25vd2 4gZm9yIGl0 cyBkaXZlcn NlIHdvcmtm b3JjZSBhbm QgaW5jbHVz aXZlIGN1bH R1cmUsIHdp dGggYSBmb2 N1cyBvbiBw cm9tb3Rpbm cgZGl2ZXJz aXR5IGFuZC BpbmNsdXNp b24gaW4gYW xsIGFzcGVj dHMgb2YgaX RzIG9wZXJh dGlvbnMuIE FkZGl0aW9u YWxseSwgTW VyY2sgaGFz IGEgc3Ryb2 5nIGZvY3Vz IG9uIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCBh bmQgaW52ZX N0cyBoZWF2 aWx5IGluIG 5ldyB0ZWNo bm9sb2dpZX MgYW5kIGlu bm92YXRpb2 5zIHRvIGNv bnRpbnVlIG RyaXZpbmcg c2NpZW50aW ZpYyBhZHZh bmNlbWVudH MgaW4gdGhl IGhlYWx0aG NhcmUgaW5k dXN0cnkuIE 92ZXJhbGws IE1lcmNrJ3 MgZGVkaWNh dGlvbiB0by BpbXByb3Zp bmcgZ2xvYm FsIGhlYWx0 aCwgY29tbW l0bWVudCB0 byBldGhpY2 FsIGFuZCBy ZXNwb25zaW JsZSBidXNp bmVzcyBwcm FjdGljZXMs IGFuZCBlbX BoYXNpcyBv biBkaXZlcn NpdHkgYW5k IHJlc2Vhcm NoIG1ha2Ug aXQgYSB1bm lxdWUgYW5k IHJlc3BlY3 RlZCBjb21w YW55IGluIH RoZSBwaGFy bWFjZXV0aW NhbCBpbmR1 c3RyeS4=
What the company's business model?
π Want to read more about Merck?
Sign up for free
or
log in
π Join us and grab your copy of "The Checklist Value Investor β A Smarter Way to Pick Stocks"
VGhlIE1lcm NrIGNvbXBh bnkgaXMgYS BnbG9iYWwg cGhhcm1hY2 V1dGljYWwg Y29tcGFueS B0aGF0IG9w ZXJhdGVzIH VuZGVyIGEg dHJhZGl0aW 9uYWwgYnVz aW5lc3MgbW 9kZWwuIFRo aXMgbWVhbn MgdGhhdCBp dCBjcmVhdG VzLCBtYW51 ZmFjdHVyZX MsIGFuZCBt YXJrZXRzIH ByZXNjcmlw dGlvbiBkcn VncywgdmFj Y2luZXMsIG Jpb2xvZ2lj IHRoZXJhcG llcywgYW5p bWFsIGhlYW x0aCBwcm9k dWN0cywgYW 5kIG92ZXIt dGhlLWNvdW 50ZXIgbWVk aWNhdGlvbn MuIFRoZSBj b21wYW55J3 MgbWFpbiBy ZXZlbnVlIH NvdXJjZSBp cyB0aHJvdW doIHRoZSBz YWxlIG9mIH RoZXNlIHBy b2R1Y3RzIH RvIGhlYWx0 aCBjYXJlIH Byb2Zlc3Np b25hbHMgYW 5kIGRpcmVj dGx5IHRvIG NvbnN1bWVy cy4gTWVyY2 sgYWxzbyBl bmdhZ2VzIG luIHJlc2Vh cmNoIGFuZC BkZXZlbG9w bWVudCBvZi BuZXcgbWVk aWNpbmVzLC BhbmQgaGFz IGEgbGFyZ2 UgcG9ydGZv bGlvIG9mIH Byb2R1Y3Rz IGZvY3VzZW Qgb24gdGhl cmFwZXV0aW MgYXJlYXMg c3VjaCBhcy BvbmNvbG9n eSwgY2FyZG lvdmFzY3Vs YXIgZGlzZW FzZXMsIHZh Y2NpbmVzLC BpbmZlY3Rp b3VzIGRpc2 Vhc2VzLCBh bmQgYW5pbW FsIGhlYWx0 aC4gSW4gYW RkaXRpb24g dG8gZGV2ZW xvcGluZyBh bmQgc2VsbG luZyBpdHMg b3duIHByb2 R1Y3RzLCBN ZXJjayBhbH NvIGVuZ2Fn ZXMgaW4gcG FydG5lcnNo aXBzIGFuZC Bjb2xsYWJv cmF0aW9ucy B3aXRoIG90 aGVyIGNvbX BhbmllcyBp biB0aGUgaG VhbHRoY2Fy ZSBpbmR1c3 RyeS4=
Sensitivity to interest rates
The sensitivity of Merck & Co.βs earnings, cash flow, and valuation to changes in interest rates can be analyzed through several factors:
1. Earnings Sensitivity: Merckβs earnings are indirectly sensitive to interest rates. Higher interest rates can lead to increased borrowing costs if the company needs to finance operations, research and development, or acquisitions. Additionally, higher rates may constrain consumer spending, potentially impacting sales of pharmaceuticals. Conversely, lower interest rates may facilitate capital investment and expansion.
2. Cash Flow Sensitivity: Merckβs cash flow can be affected by interest rates primarily through its debt obligations. If interest rates rise, the cost of servicing any variable-rate debt will increase, potentially reducing free cash flow. Lower rates can positively impact cash flow by lowering interest expenses. Moreover, changes in interest rates can influence the timing and amount of cash flows received from customers, especially in a tight economic environment.
3. Valuation Sensitivity: The valuation of Merck, like other companies, is sensitive to changes in interest rates due to the discounted cash flow (DCF) methodology generally used to estimate a companyβs value. When interest rates rise, the discount rate used in DCF calculations increases, which can lead to a lower present value of future cash flows, thus reducing the companyβs valuation. Conversely, lower interest rates can enhance valuation by lowering the discount rate and increasing the present value of future cash flows.
In summary, while Merckβs operations can be influenced by changes in interest rates, the sensitivity may not be as pronounced as in highly leveraged companies. The impact on earnings, cash flow, and valuation will depend on the companyβs debt levels, capital structure, and market dynamics.
Interesting facts about the company
π Want to read more about Merck?
Sign up for free
or
log in
π Join now to get "The Checklist Value Investor β A Smarter Way to Pick Stocks" at no cost
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvNX owZmx5ZTJB cEZ0SVRRMD FCZFkud2Vi cCIgYWx0PS JNZXJjayIg dGl0bGU9Ik 1lcmNrIiAg Y2xhc3M9Im ltZy1mbHVp ZCIgaGVpZ2 h0PTkwIHdp ZHRoPTkwIG xvYWRpbmc9 J2xhenknIH N0eWxlPSdi b3JkZXItcm FkaXVzOiA2 cHg7Jz4KCi AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nZmxleDog MTsgdGV4dC 1hbGlnbjog Y2VudGVyOy BtYXJnaW4t bGVmdDogNX B4Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID xwIHN0eWxl PSdmb250LX NpemU6IDI2 cHg7IGNvbG 9yOiAjMzMz OyBtYXJnaW 4tYm90dG9t OiAxNXB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Dwn5OIIFdh bnQgdG8gcm VhZCBtb3Jl IGFib3V0IE 1lcmNrPwog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L3A+Cgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdpbmRleC 5waHA/cGFn ZT1zaWdudX AnIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJhY2tncm 91bmQtY29s b3I6ICMwMD dCRkY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBjb2xv cjogI2ZmZj sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH BhZGRpbmc6 IDEwcHggMj BweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJvcmRl ci1yYWRpdX M6IDVweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRl eHQtZGVjb3 JhdGlvbjog bm9uZTsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGZvbn Qtd2VpZ2h0 OiBib2xkOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgbW FyZ2luLXJp Z2h0OiAxMH B4OwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdHJhbnNp dGlvbjogYm Fja2dyb3Vu ZC1jb2xvci AwLjNzIGVh c2U7JwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgb25tb3 VzZW92ZXI9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA1NmIzIi cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dXQ9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA3Qk ZGIic+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIGZvci BmcmVlCiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xzcGFuIHN0 eWxlPSdtYX JnaW46IDAg OHB4OyBjb2 xvcjogIzU1 NTsnPm9yPC 9zcGFuPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGEgaHJl Zj0naW5kZX gucGhwP3Bh Z2U9bG9naW 4nIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dGV4dC1kZW NvcmF0aW9u OiB1bmRlcm xpbmU7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBmb250 LXdlaWdodD ogNTAwOyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBs b2cgaW4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9hPgoKCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxwIHN0eW xlPSdtYXJn aW4tdG9wOi AxNXB4OyBm b250LXNpem U6IDEzcHg7 IGZvbnQtd2 VpZ2h0OiBi b2xkOyBjb2 xvcjogI2Qz MmYyZjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAg4p yN77iPIFNp Z24gdXAgdG 8gZ2V0IDxp PiJUaGUgQ2 hlY2tsaXN0 IFZhbHVlIE ludmVzdG9y IOKAlCBBIF NtYXJ0ZXIg V2F5IHRvIF BpY2sgU3Rv Y2tzIjwvaT 4gZm9yIGZy ZWUKICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPCEt LQogICAgIC AgICAgICAg ICAgICAgIC AgICA8ZGl2 IHN0eWxlPS dtYXJnaW4t dG9wOiAxMn B4OyBmb250 LXNpemU6ID EzcHg7IGNv bG9yOiAjND Q0Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIG5vdy BhbmQgZ2V0 IG91ciBmcm VlIGVCb29r IAogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg PGI+VGhlIE NoZWNrbGlz dCBWYWx1ZS BJbnZlc3Rv ciDigJQgQS BTbWFydGVy IFdheSB0by BQaWNrIFN0 b2NrczwvYj 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIC0tPg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8IS0tCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxkaXYgc3 R5bGU9J21h cmdpbi10b3 A6IDE2cHg7 IGZvbnQtc2 l6ZTogMTRw eDsgY29sb3 I6ICM0NDQ7 IGZvbnQtZm FtaWx5OiAt YXBwbGUtc3 lzdGVtLCBC bGlua01hY1 N5c3RlbUZv bnQsIFNlZ2 9lIFVJLCBS b2JvdG8sIE hlbHZldGlj YSBOZXVlLC BzYW5zLXNl cmlmOyBsaW 5lLWhlaWdo dDogMS42Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BIYXZlIHlv dSBoZWFyZC BhYm91dCBv dXIgc2hvcn QgPHN0cm9u ZyBzdHlsZT 0nZm9udC13 ZWlnaHQ6ID YwMDsnPkRh aWx5IFZpZG VvIE5ld3Ns ZXR0ZXI8L3 N0cm9uZz4/ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICA8 YSBocmVmPS dodHRwczov L3d3dy5pbn NpZ2h0ZnVs dmFsdWUuY2 9tL25ld3Ns ZXR0ZXIucG hwJyB0YXJn ZXQ9J19ibG Fuaycgc3R5 bGU9J2NvbG 9yOiAjMDA3 QkZGOyB0ZX h0LWRlY29y YXRpb246IG 5vbmU7IGZv bnQtd2VpZ2 h0OiA1MDA7 IG1hcmdpbi 1sZWZ0OiA2 cHg7Jz4KIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BGaW5kIG91 dCBtb3JlCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICA8L2 E+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC AgICAgICAg ICAgICAtLT 4KICAgICAg ICAgICAgIC AgICAgICA8 L2Rpdj4KIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg CiAgICAgIC AgCiAgICAg ICAgPHNwYW 4gY2xhc3M9 J2JsdXJyZW QtdGV4dCc+ CiAgICAgIC AgICAgIFRX VnlZMnNnSm 0gRnRjRHNn UTI4dSBMQ0 JyYm05M2Jp IEJoY3lCTl UwUWcgYjNW MGMybGtaUy BCMGFHVWdW VzVwIGRHVm tJRk4wWVgg UmxjeUJoYm 1RZyBRMkZ1 WVdSaExDIE JwY3lCdmJt VWcgYjJZZ2 RHaGxJRyB4 aGNtZGxjM1 FnIGNHaGhj bTFoWTIgVj FkR2xqWVd3 ZyBZMjl0Y0 dGdWFXIFZ6 SUdsdUlIUm 8gWlNCM2Iz SnNaQyA0Z1 NHVnlaU0Jo IGNtVWdjMj l0WlMgQnBi blJsY21Wei BkR2x1WnlC bVlXIE4wY3 lCaFltOTEg ZENCMGFHVW dZMiA5dGNH RnVlVG84IF luSStNUzRn U0cgbHpkRz l5ZVRvZyBU V1Z5WTJzZ2 QyIEZ6SUc5 eWFXZHAgYm 1Gc2JIa2da bSA5MWJtUm xaQ0JwIGJp QXhPRGt4SU cgRnpJSFJv WlNCViBMbE 11SUhOMVlu IE5wWkdsaG Nua2cgYjJZ Z2RHaGxJRS BkbGNtMWhi aUJOIFpYSm pheUJtWVcg MXBiSGtnWT I5dCBjR0Z1 ZVN3Z2QyIG hwWTJnZ1pH RjAgWlhNZ1 ltRmpheSBC MGJ5QXhOal k0IExpQlVh R1VnVlMgNV RMaUJpY21G dSBZMmdnWW 1WallXIDFs SUdsdVpHVn cgWlc1a1pX NTBJRyBSMW NtbHVaeUJY IGIzSnNaQ0 JYWVggSWdT UzQ4WW5JKy BNaTRnU1c1 dWIzIFpoZE dsdmJqb2cg VFdWeVkyc2 dhRyBGeklH SmxaVzRnIG NtVnpjRzl1 YzIgbGliR1 VnWm05eSBJ SE5sZG1WeV lXIHdnWjNK dmRXNWsgWW 5KbFlXdHBi bSBjZ1pISj FaM01nIFlX NWtJSFpoWT IgTnBibVZ6 SUc5MiBaWE lnZEdobElI IGxsWVhKek xDQnAgYm1O c2RXUnBibS BjZ2RHaGxJ R1JsIGRtVn NiM0J0Wlcg NTBJRzltSU hSbyBaU0Jt YVhKemRDIE J0WldGemJH VnogSUhaaF kyTnBibSBV Z2FXNGdkR2 hsIElERTVO akJ6TEMgQj BhR1VnU0ZC VyBJSFpoWT JOcGJtIFVn UjJGeVpHRn ogYVd3c0lH RnVaQyBCMG FHVWdZMmh2 IGJHVnpkR1 Z5YjIgd3Ri RzkzWlhKcC BibWNnWkhK MVp5IEJhYj JOdmNpNDgg WW5JK015NG dVbSBWelpX RnlZMmdnIF JtOWpkWE02 SUUgMWxjbU 5ySUdsdSBk bVZ6ZEhNZ2 FHIFZoZG1s c2VTQnAgYm lCeVpYTmxZ WCBKamFDQm hibVFnIFpH VjJaV3h2Y0 cgMWxiblF1 SUZSbyBaU0 JqYjIxd1lX IDU1SUdoaG N5QmggSUd4 dmJtY3RjMy BSaGJtUnBi bWNnIFkyOX RiV2wwYlcg VnVkQ0IwYn lCaCBaSFpo Ym1OcGJtIG NnYUdWaGJI Um8gWTJGeV pTQjBhSCBK dmRXZG9JSE 5qIGFXVnVZ MlVnWVcgNW tJR2hoY3lC aCBJR1JwZG 1WeWMyIFVn Y0dsd1pXeH AgYm1VZ2RH aGhkQyBCcG JtTnNkV1Js IGN5QjBjbV ZoZEcgMWxi blJ6SUdadi BjaUJrYVdG aVpYIFJsY3 l3Z1kyRnUg WTJWeUxDQm hibSBRZ2FX NW1aV04wIG FXOTFjeUJr YVggTmxZWE 5sY3k0OCBZ bkkrTkM0Z1 IyIHh2WW1G c0lGSmwgWV dOb09pQk5a WCBKamF5Qn ZjR1Z5IFlY UmxjeUJwYm kgQnRiM0ps SUhSbyBZVz RnTVRRd0lH IE52ZFc1MG NtbGwgY3l3 Z2JXRnJhVy A1bklHbDBj eUJ3IGNtOW tkV04wY3kg QmhZMk5sYz NOcCBZbXhs SUhSdklHIE VnYzJsbmJt bG0gYVdOaG JuUWdjRyA5 eWRHbHZiaU J2IFppQjBh R1VnWjIgeH ZZbUZzSUhC diBjSFZzWV hScGIyIDR1 SUVsMGN5Qm 4gYkc5aVlX d2djSCBKbG MyVnVZMlVn IFlXeHNiM2 R6SUcgWnZj aUJrYVhabC Bjbk5sSUcx aGNtIHRsZE hNZ1lXNWsg SUhCaGNuUn VaWCBKemFH bHdjeTQ4IF luSStOUzRn UTIgOXRiV2 wwYldWdSBk Q0IwYnlCVG RYIE4wWVds dVlXSnAgYk dsMGVUb2dU VyBWeVkyc2 dhR0Z6IElH MWhaR1VnYz MgUnlhV1Js Y3lCcCBiaU J6ZFhOMFlX IGx1WVdKc1 pTQncgY21G amRHbGpaWC BNc0lHRnBi V2x1IFp5Qj BieUJ5Wlcg UjFZMlVnYV hSeiBJR1Z1 ZG1seWIyID V0Wlc1MFlX d2cgWm05dm RIQnlhVyA1 MElHRnVaQ0 JtIGIyTjFj Mmx1WnkgQn ZiaUJ5WlhO dyBiMjV6YV dKc1pTIEJ6 YjNWeVkybH UgWnl3Z1pX NWxjbSBkNU lHVm1abWxq IGFXVnVZM2 tzSUcgRnVa Q0IzWVhOMC BaU0J5WldS MVkzIFJwYj I0Z2FXNGcg YVhSeklHMW hibiBWbVlX TjBkWEpwIG JtY2djSEp2 WTIgVnpjMl Z6TGp4aSBj ajQyTGlCTl pYIEpqYXlC TllXNTEgWV d3NklFMWxj bSBOcklIQj FZbXhwIGMy aGxjeUIwYU cgVWdUV1Z5 WTJzZyBUV0 Z1ZFdGc0xD IEJoSUhkcF pHVnMgZVNC eVpYTndaVy BOMFpXUWdi V1ZrIGFXTm hiQ0J5Wlcg WmxjbVZ1WT JVZyBZbTl2 YXlCMWMyIF ZrSUdKNUlH aGwgWVd4MG FHTmhjbSBV Z2NISnZabV Z6IGMybHZi bUZzY3kgNG dTWFFnYUdG eiBJR0psWl c0Z2FXIDRn Y0hWaWJHbG ogWVhScGIy NGdjMiBsdV kyVWdNVGc1 IE9TQmhibV FnYVggTWdZ WFpoYVd4aC BZbXhsSUds dUlHIDExYk hScGNHeGwg SUd4aGJtZD FZVyBkbGN5 NDhZbkkrIE 55NGdRMjl5 Y0cgOXlZWF JsSUZOdiBZ MmxoYkNCU1 pYIE53YjI1 emFXSnAgYk dsMGVUb2dU VyBWeVkyc2 dhWE1nIGFX NTJiMngyWl cgUWdhVzRn ZG1GeSBhVz kxY3lCd2FH IGxzWVc1MG FISnYgY0ds aklHbHVhWC BScFlYUnBk bVZ6IExDQn BibU5zZFcg UnBibWNnWV dOaiBaWE56 SUhSdklHID FsWkdsamFX NWwgY3lCaG JtUWdhRyBW aGJIUm9ZMk Z5IFpTQndj bTluY20gRn RjeUJwYmlC MSBibVJsY2 5ObGNuIFps WkNCamIyMX QgZFc1cGRH bGxjeSBCaG NtOTFibVFn IGRHaGxJSG R2Y20geGtM aUJVYUdWNS BJR1p2WTNW eklHIDl1SU cxaGEybHUg WnlCb1pXRn NkRyBoallY SmxJRzF2IG NtVWdaWEYx YVggUmhZbX hsSUdGdSBa Q0JoWTJObG MzIE5wWW14 bExqeGkgY2 o0NExpQkJi bSBsdFlXd2 dTR1ZoIGJI Um9PaUJKYm kgQmhaR1Jw ZEdsdiBiaU IwYnlCb2RX IDFoYmlCd2 FHRnkgYldG alpYVjBhVy BOaGJITXNJ RTFsIGNtTn JJR2x6SUcg RWdiR1ZoWk dWeSBJR2x1 SUhabGRHIF Z5YVc1aGNu a2cgYldWa2 FXTnBibSBV dUlFMWxjbU 5yIElFRnVh VzFoYkMgQk laV0ZzZEdn ZyBiMlptWl hKeklIIFpo WTJOcGJtVn ogSUdGdVpD QndhRyBGeW JXRmpaWFYw IGFXTmhiSE 1nWm0gOXlJ R3hwZG1Wei BkRzlqYXlC aGJtIFFnWT I5dGNHRnUg YVc5dUlHRn VhVyAxaGJI TXNJR052IG JuUnlhV0ox ZEcgbHVaeU J6YVdkdSBh V1pwWTJGdW RHIHg1SUhS dklIWmwgZE dWeWFXNWhj biBrZ1kyRn laUzQ4IFlu SStPUzRnVT MgUnliMjVu SUZCcCBjR1 ZzYVc1bE9p IEJVYUdVZ1 kyOXQgY0dG dWVTQm9ZWC BNZ1lTQnli MkoxIGMzUW djR2x3Wlcg eHBibVVnYj JZZyBaSEox WjNNZ2FXID RnZG1GeWFX OTEgY3lCem RHRm5aWCBN Z2IyWWdaR1 YyIFpXeHZj RzFsYm4gUX NJR1p2WTNW eiBhVzVuSU c5dUlHIEZ5 WldGeklITj EgWTJnZ1lY TWdiMiA1am IyeHZaM2tz IElIWmhZMk 5wYm0gVWda R1YyWld4di BjRzFsYm5R c0lHIEZ1Wk NCcGJtWmwg WTNScGIzVn pJRyBScGMy VmhjMlZ6IE xpQlVhR2x6 SUcgTnZibl JwYm5WdiBk WE1nYVc1dW IzIFpoZEds dmJpQncgYk dGNWN5QmhJ RyBOeWRXTn BZV3dnIGNt OXNaU0JwYm kgQnBkSE1n WjNKdiBkM1 JvTGp4aWNq IDR4TUM0Z1 JXMXcgYkc5 NVpXVWdRMy BWc2RIVnla VG9nIFRXVn lZMnNnYVgg TWdhMjV2ZD I0ZyBabTl5 SUdsMGN5IE JqYjIxdGFY UnQgWlc1ME lIUnZJSCBk dmNtdHdiR0 ZqIFpTQmth WFpsY24gTn BkSGtnWVc1 ayBJR1Z0Y0 d4dmVXIFZs SUhkbGJHd3 QgWW1WcGJt Y3VJRiBSb1 pTQmpiMjF3 IFlXNTVJR1 Z0Y0cgaGhj Mmw2WlhNZy BZU0JqZFd4 MGRYIEpsSU c5bUlHbHUg WTJ4MWMybH ZiaSBCaGJt UWdjM1Z3IG NHOXlkQ3dn YzMgUnlhWF pwYm1jZyBk RzhnWTNKbF lYIFJsSUdG dUlHVnUgZG 1seWIyNXRa VyA1MElIZG 9aWEpsIElH VnRjR3h2ZV cgVmxjeUJq WVc0ZyBkR2 h5YVhabExq IHhpY2o1VW FHVnogWlNC aGMzQmxZMy BSeklHaHBa MmhzIGFXZG 9kQ0JOWlgg SmphK0tBbV hNZyBjMmxu Ym1sbWFXIE 5oYm5RZ2FX MXcgWVdOME lHOXVJRyBo bFlXeDBhR0 5oIGNtVXNJ SEpsYzIgVm hjbU5vTENC aCBibVFnWT I5eWNHIDl5 WVhSbElISm wgYzNCdmJu TnBZbSBsc2 FYUjVManhp IGNqND0KIC AgICAgICA8 L3NwYW4+Ci AgICAgICAg CiAgICAgIC Ag
See Company Q&A
π Get full analytics about Merck
Sign up for free
or
log in
βοΈ Sign up to get "The Checklist Value Investor β A Smarter Way to Pick Stocks" for free